SG Americas Securities LLC Raises Stake in CVS Health Corporation $CVS

SG Americas Securities LLC raised its position in CVS Health Corporation (NYSE:CVS) by 13.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,228,069 shares of the pharmacy operator’s stock after purchasing an additional 147,827 shares during the period. SG Americas Securities LLC’s holdings in CVS Health were worth $87,459,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Evolve Private Wealth LLC grew its stake in shares of CVS Health by 6.4% during the first quarter. Evolve Private Wealth LLC now owns 56,568 shares of the pharmacy operator’s stock worth $4,063,000 after purchasing an additional 3,426 shares in the last quarter. Meadowbrook Advisors Group LLC acquired a new stake in CVS Health in the first quarter valued at $313,000. Triad Wealth Partners LLC lifted its holdings in CVS Health by 14.8% during the 1st quarter. Triad Wealth Partners LLC now owns 3,561 shares of the pharmacy operator’s stock worth $256,000 after buying an additional 459 shares during the last quarter. Park National Corp OH boosted its position in shares of CVS Health by 13.0% during the 1st quarter. Park National Corp OH now owns 157,794 shares of the pharmacy operator’s stock worth $11,333,000 after acquiring an additional 18,117 shares in the last quarter. Finally, Founders Financial Securities LLC increased its holdings in shares of CVS Health by 6.0% in the 1st quarter. Founders Financial Securities LLC now owns 32,469 shares of the pharmacy operator’s stock valued at $2,560,000 after acquiring an additional 1,835 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 0.1%

Shares of NYSE CVS opened at $98.26 on Monday. The business has a 50-day moving average price of $89.31 and a 200 day moving average price of $81.50. The stock has a market cap of $125.38 billion, a PE ratio of 43.29, a price-to-earnings-growth ratio of 0.96 and a beta of 0.62. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a 52-week low of $58.50 and a 52-week high of $102.77.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, topping the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company had revenue of $100.43 billion for the quarter, compared to analyst estimates of $94.99 billion. During the same quarter in the previous year, the company posted $2.25 earnings per share. The firm’s revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts forecast that CVS Health Corporation will post 7.44 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their target price on CVS Health from $101.00 to $111.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. Wells Fargo & Company increased their price target on shares of CVS Health from $102.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Robert W. Baird raised their price objective on shares of CVS Health from $92.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Sunday. Finally, DA Davidson increased their target price on shares of CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Twenty-two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $100.68.

Insiders Place Their Bets

In other news, Director Larry Robbins sold 1,983,538 shares of CVS Health stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $94.45, for a total value of $187,345,164.10. Following the transaction, the director directly owned 6,213,261 shares of the company’s stock, valued at $586,842,501.45. The trade was a 24.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Tilak Mandadi sold 69,551 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. This represents a 87.28% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,441,551 shares of company stock worth $323,703,977 over the last ninety days. Corporate insiders own 0.85% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.